BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11368792)

  • 1. Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways.
    Ding S; Yao D; Deeni YY; Burchell B; Wolf CR; Friedberg T
    Biochem J; 2001 Jun; 356(Pt 2):613-9. PubMed ID: 11368792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dimethyl sulfoxide on the function of cytochrome P450 2D6 in HepG2 cells upon the co-expression with NADPH-cytochrome P450 reductase.
    Narimatsu S; Takatsu N; Yamano S; Inoue Y; Hanioka N; Kiryu K; Naito S; Gonzalez FJ; Yamamoto S
    Chem Biol Interact; 2006 Jan; 159(1):47-57. PubMed ID: 16214121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris.
    Dietrich M; Grundmann L; Kurr K; Valinotto L; Saussele T; Schmid RD; Lange S
    Chembiochem; 2005 Nov; 6(11):2014-22. PubMed ID: 16222729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation.
    Ding S; Yao D; Burchell B; Wolf CR; Friedberg T
    Arch Biochem Biophys; 1997 Dec; 348(2):403-10. PubMed ID: 9434754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coli.
    Pritchard MP; Glancey MJ; Blake JA; Gilham DE; Burchell B; Wolf CR; Friedberg T
    Pharmacogenetics; 1998 Feb; 8(1):33-42. PubMed ID: 9511179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein.
    Deeni YY; Paine MJ; Ayrton AD; Clarke SE; Chenery R; Wolf CR
    Arch Biochem Biophys; 2001 Dec; 396(1):16-24. PubMed ID: 11716457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells.
    Schneider A; Schmalix WA; Siruguri V; de Groene EM; Horbach GJ; Kleingeist B; Lang D; Böcker R; Belloc C; Beaune P; Greim H; Doehmer J
    Arch Biochem Biophys; 1996 Aug; 332(2):295-304. PubMed ID: 8806738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase.
    Modi S; Gilham DE; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
    Biochemistry; 1997 Apr; 36(15):4461-70. PubMed ID: 9109653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.
    Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T
    J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
    Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
    J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
    Lengler J; Omann M; Düvier D; Holzmüller H; Gregor W; Salmons B; Günzburg WH; Renner M
    Biochem Pharmacol; 2006 Sep; 72(7):893-901. PubMed ID: 16887103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase.
    Sugishima M; Sato H; Higashimoto Y; Harada J; Wada K; Fukuyama K; Noguchi M
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2524-9. PubMed ID: 24550278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of NADPH in the interaction between heme oxygenase-1 and cytochrome P450 reductase.
    Higashimoto Y; Sakamoto H; Hayashi S; Sugishima M; Fukuyama K; Palmer G; Noguchi M
    J Biol Chem; 2005 Jan; 280(1):729-37. PubMed ID: 15516695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen.
    Dong H; Haining RL; Thummel KE; Rettie AE; Nelson SD
    Drug Metab Dispos; 2000 Dec; 28(12):1397-400. PubMed ID: 11095574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent.
    Loeper J; Louérat-Oriou B; Duport C; Pompon D
    Mol Pharmacol; 1998 Jul; 54(1):8-13. PubMed ID: 9658184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.
    Gu J; Weng Y; Zhang QY; Cui H; Behr M; Wu L; Yang W; Zhang L; Ding X
    J Biol Chem; 2003 Jul; 278(28):25895-901. PubMed ID: 12697746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer.
    Yanatori I; Richardson DR; Toyokuni S; Kishi F
    J Biol Chem; 2017 Aug; 292(32):13205-13229. PubMed ID: 28655775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of human cytochrome P450 2D6 drug metabolites with recombinant microbes--a comparative study.
    Geier M; Braun A; Emmerstorfer A; Pichler H; Glieder A
    Biotechnol J; 2012 Nov; 7(11):1346-58. PubMed ID: 22930520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism.
    Bostick CD; Hickey KM; Wollenberg LA; Flora DR; Tracy TS; Gannett PM
    Drug Metab Dispos; 2016 May; 44(5):741-9. PubMed ID: 26961240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
    Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
    Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.